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Solution small angle X-ray scattering from biological macromolecules (BioSAXS) plays an increasingly
important role in biostructural research. The analysis of complex protein mixtures, dynamic equilib-
riums, intrinsic disorder and evolving structural processes is facilitated by SAXS data, either in stand-
alone applications, or with SAXS taking a prominent role in hybrid biostructural analysis. This is not
the least due to the signiﬁcant advances in both hardware and software that have taken place in
particular at the large-scale facilities. Here, recent developments and the future potential of BioSAXS are
reviewed, exempliﬁed by numerous examples of elegant applications to challenging systems.
© 2016 The Author. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Frontiers in biostructural analysis
Prime challenges in biostructural analysis today include the
investigation of structural changes, dynamics and polydispersity.
The accurate and detailed description of biomacromolecules,
derived from high-resolution structures and primarily originating
from macromolecular crystallography (MX), has provided the
research community with a wealth of insight, greatly enabling our
current understanding of biomolecular function. Bio-
macromolecules, however, are inherently dynamic at several time-
and length-scales [1], and this dynamic behavior is crucial for their
biological function. The cell is a crowded and ever-changing envi-
ronment where proteins, lipids, nucleic acids, polysaccharides and
other biomolecules interact in a structurally responsive and adap-
tive manner. A single protein structure should thus not be consid-
ered as a three-dimensional rigidly deﬁned entity, but rather belution scattering; SAXS, small
attering; BioSAXS, biological
C-SAXS, size exclusion chro-
time resolved; ISpyB, Infor-
; ISpyBB, ISpyB for BioSAXS;
ng Biological Data Bank; PDB,
IDP, intrinsically disordered
romolecular crystallography;
in Crystallography, edited by
Inc. This is an open access articleunderstood as a spatiotemporal distribution of an ill-deﬁned
number of conformational states, and this ensemble of conforma-
tions deﬁnes the biological function of the protein. Likewise, when
considering macromolecular interactions (e.g. protein:protein in-
teractions [2]), structural polydispersity plays a signiﬁcant role:
often complexes are only partially and/or transiently formed, and
complex formation in addition may induce or require different
levels of conformational changes of the individual protomers. One
may say that the functionality of macromolecular interactions is
deﬁned by a highly reﬁned interplay between two macromolecular
entities, each deﬁned as a complex ensemble of structures, and that
this interplay introduces an additional level of structural
complexity, not exhibited by each individual structure prior to the
encounter.
This view on structures challenges biostructural analysis in gen-
eral, and high-resolution structural investigation in particular. Small
angle scattering (SAS), on the other hand, is uniquely suited for these
experimental endeavors. In a SAS experiment the sample is in the
liquid state, and the experiment can be performed under physio-
logically or otherwise experimentally relevant conditions, since there
are no particular requirements to sample preparation. SAS is a low-
resolution method, and hence by no means replaces, but rather
uniquely complements high-resolution biostructural analysis. As a
consequence, the SAS community is experiencing an almost explo-
sive development in numerous ways: the available software and
hardware rapidly advances, the complexity of the scientiﬁc questions
that are addressed is continuously increasing [3], and there is an ever-under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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production [4]. Indeed, the days where SAS was the last resort for the
crystallographer in spe are over, and the era where SAS greatly em-
powers biostructural understanding is ongoing.
2. Increasing data quality and decreasing sample quantity
The intensities of X-rays and, to a lesser extent, neutrons at in-
ternational large-scale facilities are dramatically increasing. This
drives impressive hardware advances at the leading established and
upcoming facilities within both biological solution small angle X-ray
scattering (BioSAXS) [5e11] and neutron scattering (BioSANS) [12]
facilities. Not only have the beam parameters (such as brilliance
and positional stability) constantly improved, so have the front-end
hardware and software developments, the latter dramatically
increasing user-friendliness. At several BioSAXS facilities robotics
ensure low sample consumption and robust, rapid samplemounting
[7,13,14]. Thereby, not only is sample/data-throughput signiﬁcantly
improved, also, the standardizedmountingminimizes usermistakes
and includes an optimized cleaning procedure, while oscillation of
the sample in the capillary diminishes radiation damage, with the
net effect of improved data quality. The sensitivity and speed of
detectors has also undergone revolutionary development, and one
consequence is that now, multiple data-frames from very short ex-
posures are collected for the data collection from a single sample,
rather than performing one long exposure. This enables comparison
of individual data-frames, and hence detection of potential radiation
damage from the high-brilliance X-ray beams, thereby ensuring that
the ﬁnal dataset for a given sample is averaged only from the frames
devoid of radiation damage.
A highly useful tool which was recently developed, and which,
among many other useful applications, can detect the potential
onset of radiation damage during multiple exposures, is the cor-
relation map (CorMap) [15]. With this tool, it is possible to perform
pair-wise or multiple comparisons of data-curves, independent of
the error estimates. The method is highly sensitive, and has a large
range of important applications, some of which are mentioned in
this review. One example, applied during data collection, is the
continuous monitoring of the cleanliness of the sample cell. If
collecting a large number of datasets, repeated buffer measure-
ments can be compared, and should correlate perfectly, if the
sample cell remains clean. The implementation of such automated
procedures at the advanced beamlines greatly enhances the output
for users visiting the facilities.
Also, the greatest part of basic data reduction, processing and
analysis has been automated. These routines have been included in
a major pipeline of data evaluation which call individual advanced
software packages, providing the user with on-the-spot informa-
tion about data quality, biophysical parameters and ab initio
structures [16]. These and other automated procedures are also
included in ISpyBB (Information System for Protein crystallography
Beamlines (ISpyB) for BioSAXS) [17]. ISpyBB integrates data-
management from the point of preparing the samples (strategy
for data collection, calculation of the needed sample quantities
etc.), over logging and controlling the data collection to providing
the results of the initial automated data analysis in a GUI. In addi-
tion IspyBB enables access to and comparison with relevant data
from the same or previous data collections [17]. With low sample
consumption and rapid data collection BioSAXS users collect tens,
hundreds, and sometimes thousands of datasets within a project
period, which increases demands for comparative data evaluation,
or even data archiving and tracking. It is planned to expand the
program, such that the measured data guides additional sample
preparation using liquid-handling robotics at high-throughput
crystallization facilities. As an example, if the SAXS data revealthat certain conditions promote complex formation and minimize
unspeciﬁc aggregation, the following data collection will use these
or further optimized experimental conditions [17] which ultimately
enables a scanning of a multidimensional experimental space,
searching for relevant structural states of the investigated macro-
molecules [18].
Even lower sample consumption can be achieved by the use of
microﬂuidic sample environments [6,18e21]. Some microﬂuidic
systems aim at providing versatile off-the-shelf sample environ-
ments for standard screening purposes, however, microﬂuidics have
also in several cases been applied in a customized setup with a
particular purpose, such as the screening of structural changes in
lipidic mesophases induced by the experimental conditions applied
during membrane protein crystallization attempts [22], or the on-
chip dialysis setup enabling in situ sample concentration and
buffer exchange for fragile protein samples [23]. A particularly useful
application when combining microﬂuidics and SAXS is in time-
resolved (TR) studies. In fact, microﬂuidic mixing, both stopped-
ﬂow and continuous ﬂow, has been used for more than two de-
cades for the TR study of protein and nucleic acid un- and refolding
[24e27]. TR studies are applied today with as low as nl sample
consumption [20] and to increasingly complex samples, such as the
intermediate nucleosome states during DNA unwinding [28] or in-
termediate ﬁlament formation formed under ionic gradients [29].
3. In-line sample puriﬁcation and orthogonal data
More slowly evolving mixtures can be efﬁciently analyzed using
SEC-SAXS (size exclusion chromatography coupled with BioSAXS
data collection, Fig. 1) [5,30,31]. That is, SAXS data are collected as
the sample is puriﬁed, by directing the liquid ﬂow directly from the
puriﬁcation column and through the X-ray beam. As simple as this
idea may sound, this development is by no means trivial, and has
been made possible in part because the increasing intensities at
synchrotron beamlines allow for data collection in very short time-
intervals. That is, a very large number of data-frames are collected
over the elution proﬁle, each frame of a sufﬁcient quality to allow
for individual data analysis. Individual data-frames are hence
comparatively evaluated, and data-frames from a single eluting
species can be isolated in an (semi-) automated manner [5,32e34].
SEC-SAXS can dramatically improve data quality from aggregation
prone proteins. If small amounts of un-speciﬁc aggregates co-exist
with the molecule of interest, this compromises the SAXS data, and
in many cases makes any attempt of further analysis futile. With
SEC-SAXS, however, the sample of interest is separated from these
aggregates and data are collected before the puriﬁed sample re-
aggregates. SEC-SAXS is also very useful in the case of partial
complex formation, where only a fraction of protomers form
complexes, and these complexes co-exist with the non-complexed
individual proteins (Fig. 1).
Analysis of such mixed states can be very difﬁcult without sig-
niﬁcant prior information, but SEC-SAXS often allows sufﬁcient
separation of the species such that spectra can be obtained from the
pure species. Recent examples of such successful analysis are e.g.
the studies of prion protein in complex with antibodies [36], co-
eluting monomers and dimers of intrinsically disordered alpha-
synuclein [37], monomeric, oligomeric or degradation products of
ﬁbrinogen [33], MnME:MnmG complexes of different stoichio-
metric states [38] or co-existing apo- and ligand-bound forms of
Arabidopsis thaliana acyl acid-amido synthetase [31]. A particularly
useful application is in the analysis of membrane proteins [39].
Detergent solubilized membrane protein samples are a mixture of
the protein:detergent complexes, soluble detergent and varying
amounts of detergent micelles. Since successful analysis of SAXS
data crucially relies on correct background subtraction, SAXS data
Fig. 1. SEC-SAXS data enable the analysis of partially formed complexes. In this
example, a slow-acting insulin analogue, uchI, is analyzed [35]. The protein exists in a
mixture of hexamers (not shown) and dodecamers in the presence of low amounts of
phenolic compounds. Individual insulin trimers can be in the relaxed (R, purple in
panel C) or tense (T, orange in panel C) state. A) The UV-trace of eluting dodecameric
species in the SEC-SAXS experiment, performed at the SWING beamline at synchrotron
SOLEIL. Superimposed is the Rg-estimate for individual SAXS data-frames. B) The SAXS
curve, averaged from data-frames with similar Rg-estimates. Superimposed (green) is
the ﬁt to a dodecamer in the RTTR conformation. Inset shows the resulting ab initio
model, with the high-resolution crystal structure of insulin in the RTTR conformation
embedded. C) CRYSOL-calculated theoretical scattering curves of dodecamers in
different conformations (the dimers of trimers are in RR, RT or TT conformations,
respectively). Data from Ref. [35]. Figure courtesy of M. H. Jensen.
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of detergent and micelles, but not the protein. This is however
complicated, since the exact composition of the sample is sensitive
to the presence of protein. By applying SEC-SAXS, the SAXS-data
collected from the buffer eluting in the immediate vicinity of the
protein peak provides an as-good-as-it-gets background measure-
ment and hence signiﬁcantly improves the quality of the back-
ground subtracted data, as compared to using measurements
from pre-prepared buffers [39].
In-line puriﬁcation evidently calls for a convoluted evaluation ofthe UV-trace from the eluting protein and the correlated SAXS data
at speciﬁc time-points of elution. The UV-measurement provides
the sample concentration, which can be used as input to the SAXS
data evaluation, since the scattering intensity is proportional to
sample concentration. In one setup right-angle light scattering and
refractive index detectors are also combined ex situ (but in an in-
tegrated pipeline) from the SAXS setup [5] thereby enabling inde-
pendent estimates of the molecular weight (MW) and hence
oligomeric state of the eluting protein species. Another in situ cell
successfully combines SAXS, UV, Raman and ﬂuorescence mea-
surements [40] and similar and even more advanced environments
are in development. Data collection from orthogonal data sources is
a sound principle of any structural or biophysical evaluation, and
for BioSAXS data in particular. As outlined below, the analysis of the
radially averaged 1-dimensional SAXS data curve is burdened by
ambiguity [41], which is greatly reduced when incorporating
complementary information.
4. Basic analysis and ab initio modeling: from 1D to 3D
without getting lost
To outsiders and newcomers, the process of analysis from the
radially averaged one-dimensional scattering curve (scattering in-
tensities versus themomentum transfer range q; q¼ 4psin(q)/l; 2s
is the scattering angle and l is the X-ray wavelength) to de-
scriptions of mixture compositions, structural dimensions, three-
dimensional models, structural descriptions of disordered pro-
teins, structural conversions, etc. can seem like magic. And it must
be emphasized that anymodeling based on SAS curves is associated
with ambiguity. There will be several models that equally well will
describe a given scattering curve. This fact, however, by no means
excludes the possibility to perform even detailed modeling based
on scattering data, but leaves the SAS-user with the responsibility
to very carefully report how the SAS datawere analyzed [42], and to
evaluate the suggested SAS-based models by alternative means.
Also in this light, an important progress in the community, which
eases cross-validation, elaboration and collaboration based on
BioSAXS data, is the establishment of a curated repository, the
Small Angle Scattering Biological Data Bank (SASBDB). SASBDB
enables free access to scattering data, experimental information
and derived models [43], following the guidelines recommended
by the SAS task force established under the protein data bank (PDB)
[44].
A key point for extending SAS data evaluation to advanced levels
is the inclusion of prior knowledge, when analyzing data. Prior
knowledge in this context can be many things. One example is the
knowledge that a protein structure at low resolution in solution can
be described as an undisrupted particle with a near-uniform elec-
tron density. Although such a fact may come across as a simple and
very basic fact, such restrains, when performing modeling, signif-
icantly reduce the ambiguity of modeling and guide programs to
robust solutions. Evidently, when in possession of further knowl-
edge such as the particle concentration, the protein sequence, the
oligomeric state or even partial high-resolution structures or ho-
mology models (e.g. of single domains in a multi-domain protein),
such knowledge can be efﬁciently incorporated into data analysis
routines. And, as further discussed below, the inclusion of com-
plementary data from orthogonal methods greatly empowers SAS
data analysis.
To obtain information from a sample the protein samples must
be carefullymatched by background samples, that is, samples of the
exact same composition as the protein sample, only devoid of
protein. These samples are measured and used for background
subtraction. However trivial this may sound, incorrect background
subtraction can often be the key reason for futile or (even worse)
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here. There can be several reasons for obtaining inadequate data for
background subtraction. One example was already mentioned
above in context of membrane protein analysis, where the
composition of soluble micelles is inﬂuenced by the presence of the
membrane protein, thereby complicating the measurement of the
background sample. Another reason can be (sometimes rather
extensive) interactions between buffer components and the protein
(or other macromolecule), and hence it is recommended that
sample dialysates (rather than the originally produced buffers) be
used for background measurements.
While highly complex analysis can be performed from SAS data,
it is crucial to provide signiﬁcant attention to all basic, initial data
evaluation (including evaluation of the background subtraction)
[42]. Although, as mentioned above, several beamlines now pro-
vide automated procedures for on-the-ﬂy data evaluation, this by
no means diminishes the need for a subsequent thorough manual
evaluation of the data. Rather, the automated procedures are highly
valuable because they provide the user with an overview of both
sample quality and structural parameters while collecting data,
thereby facilitating optimal use of precious sample and valuable
beamtime.
After background subtraction, it should be assessed which part
of the curve contains useful information. Even though data may
have been collected to relatively high momentum transfer range,
the data may not contain information if the noise levels are high
and the uniqueness of the curve is low, which can be evaluated [45],
and such an evaluation is implemented in some, but not all
beamlines.
At the initial points of analysis it is possible to obtain a large
number of basic biophysical parameters for the particle of interest
(such as the particle MW and hence oligomeric state, radius of
gyration (Rg), maximal dimension (Dmax) and overall shape, the
latter originating from the indirect Fourier transform of the data,
yielding the pair distance distribution function P(r)). It is always
recommended to collect data from several sample concentrations,
since comparison of such data will evidence the presence of po-
tential interactions (repulsion or attraction) between themolecules
or concentration-dependent oligomerisation of the particles. At
this point of the analysis it is often possible to detect if the sample
quality is inadequate for further analysis (e.g. presence of aggre-
gates, impurities, degradation and similar problems). In fact, SAXS
data brutally exposes the sample quality with very high sensitivity,
which is one of many reasons for the growing interest in the bio-
pharmaceutical and biotechnological industry to use BioSAXS as an
advanced screening tool in formulation development [46]. Crucial
factors in formulation development include the assessment of in-
teractions, structural and/or colloidal stability and early detection
of aggregates formation, and this can be evaluated by inspection of
the abovementioned basic biophysical parameters. With the
described development in sample handling robotics BioSAXS data
collection can be applied in a high-throughput mode, and
comparative basic data evaluation will highlight formulation dif-
ferences in a highly sensitive manner.
For a structural biology laboratory, further details are pursued
from continued analysis of the data. Very often low-resolution ab
initio modeling is pursued. Probably, the all-dominant method for
such modeling is the bead-modeling approach advocated by Sver-
gun and co-workers [47], DAMMIN [48] and DAMMIF [49]. These
programs apply a simulated annealing protocol to generate shapes
(ensembles of beads) with protein-like properties (in terms of
connectivity, electron density) that will ﬁt the scattering curves. To
reduce the challenge of ambiguity multiple constructions of models
and subsequent comparison of the spatial discrepancies among
models and averaging yield the ﬁnal models [50]. A recentapproach addresses the ambiguity problem based on the scattering
curve, i.e. prior to modeling attempts. Based on a large number of
constructed shapes a landscape of computed scattering curves is
used to identify the number of neighboring (i.e. similar) curves for a
given experimental scattering curve [51]. Curves with a low num-
ber of neighbors can hence be said to be associated with a reduced
level of ambiguity when using ab initio modeling.
Ab initio modeling can principally only be performed on data
from monodisperse samples, since the program will search for one
model to describe the scattering curve, which hence likewise must
derive from one scattering particle. A more recent development,
however, allows for the assessment of shapes from equilibrium
systems of monomers and symmetric homo-oligomers [52]. The
analysis of data from more complex mixtures demands different
approaches as discussed in the paragraph below.
5. Working with prior structural information
In the context of this special issue, the inclusion into SAXS
analysis of prior structural information from MX experiments is a
very relevant topic (Fig. 2). While MX captures atomic resolution
details, it is methodologically impossible to capture the dynamics
of the solution state including e.g. the large conformational space
covered by multi-domain proteins with extensive linkers [56,57] or
mixtures of transient and/or ﬂexible complexes [58,59]. In these
cases BioSAXS data have the capacity to uniquely complement a
high-resolution structure. As such, BioSAXS is extensively used to
(in-) validate and elaborate on the understanding of particular
conformations of multi-domain proteins or protein complexes,
observed in crystallo, e.g. the evaluation of the ubiquitin binding
site on proliferating cell nuclear antigen [60] or the orientation of
individual subdomains and ﬂexible loop areas in the multi-domain
complement component C4b [61]. For such analyses, the central
tool is a program that calculates the theoretical solution scattering
pattern based on an available high-resolution structure. Several
such programs exist. A very popular program is CRYSOL, developed
by Svergun et al. [62]. The programwas the ﬁrst to include a general
description of the solvent layer organized near the surface of the
macromolecule, which must also be included in the evaluation of
the total particle scattering. This is a non-trivial question, which
originally was addressed in a combined neutron and X-ray scat-
tering study data [63] and which has been recently re-addressed
[64]. Numerous other applications exist for calculating the theo-
retical scattering curves. There is some variation in these programs
concerning the calculation of the scattering pattern, but more
extensively debated is the principle behind the description of the
solvent layer. While CRYSOL uses a multipole expansion and
spherical harmonics to calculate a uniform solvent layer with an
extension and an average electron density that are both reﬁned in
the process [62], the program AXES includes explicit solvent
modeling, and in addition allows for the ﬁtting to numerous
explicit input structures (both the individual structures and the
average scattering pattern from all structures) [65]. The AquaSAXS
server also enables the incorporation of several pdb-ﬁles in the ﬁt,
and a choice between the use of the AquaSAXS solvent model
(which is deﬁned by orientable dipoles) [66] or a solvent layer
deﬁned by the principles behind the FoXS approach. The FoXS
program bases the solvent description on a calculation of the
atomic solvent accessible area [67] and a novel extension of the
program (MultiFoXS) includes a calculation of a large number of
potential conformations that are accessible to a ﬂexible protein and
selects ensembles, based on the branch-and-bound method [36].
The program Bayesian Ensemble SAXS (BE-SAXS) describes the
solvent layer following the same principles as in FoXS (personal
communication), but this program is developed for ensemble
Fig. 2. BioSAXS complements conventional biostructural methods. SAXS data are recorded from molecules in solution, and thus captures the dynamics of e.g. the ﬂexibility of
multidomain proteins which cannot be captured e.g. in crystallo. As an example, models of bacterial polypeptide release factor 2 (RF2), derived from different methods, are shown. A
low-resolution surface representation of RF2 is shown in red in all panels. A) Cryo-EM derived model of the in situ ribosome bound conformation. The low-resolution structure of
the bacterial ribosome binding RF2 is shown in the background [53]. B) Conformation revealed by high-resolution MX. The 1.8 Å E. coli RF2 structure [54] is in a conformation
differing signiﬁcantly from the conformation shown in panel A. C) In-complex conformation revealed by high-resolution MX. The complex between RF2 (red) and the PrmC
methylase (yellow) is shown. PrmC methylates the glutamine residue in the functionally central GGQ-loop. In this complex, the conformation of RF2 is close to that observed for RF2
alone, but distinct from the ribosome-bound conformation. D) SAXS-based solution structure, revealing an overall open solution conformation in accordance with the ribosome-
bound structure and a highly ﬂexible domain I (representative orientations shown in multiple colors) [55].
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below). And ﬁnally, the new program WAXSis elegantly imple-
ments an explicit solvent model, calculated by molecular dynamics
simulations [68,69].
While the evaluation of experimental SAXS data can be aided by
the inclusion of such prior structural information (and/or the prior
structural information can be evaluated by the SAXS data), other
programs, developed for protein structure prediction, include SAXS
data (or other data sources) as restrains in their protein structure
modeling. One such program, called PHAISTOS [70], has a SAXS
module using a coarse-grained representation of the protein (each
amino acid represented by two dummy atoms) and the Debye
formula to calculate the scattering patterns [71] reducing compu-
tational time by GPU parallel threads, but without the inclusion of a
model for the solvent layer [70]. Otherwise following approxi-
mately the same principles, the protein structure prediction suite
BCL implements an explicit solvent model in their BCL::SAXS
module [72].
The correct theoretical representation of the scattering from a
given high-resolution model is prerequisite for any further
modeling including this prior information. As mentioned, contro-
versial crystal structures have been evaluated by solution scattering
data (see examples above) but it is also possible to extend available
partial structures by SAS-based modeling. If e.g. the monomeric
structure has been crystallized, and SAS data exist for the homo-dimer, docking algorithms, attempting to identify the correct pro-
tein:protein interaction sites increase their performance when
guided by SAXS data [73e76]. Likewise if one conformation of a
given protein has been crystallized (e.g. the ligand-bound form),
the conformational changes in solution, e.g. for the apo-form, can
be evaluated using rigid body modeling approaches. In rigid body
modeling rotation of individual domains and/or protomers of a
complex [77] are guided by e.g. molecular dynamics simulations
[78]. Rigid body modeling can also include contrast variation data,
e.g. applicable to complexes with DNA/RNA, or where individual
protomers of a complex are deuterated [79]. In a recent variant of
rigid body reﬁnement, normal mode analysis deﬁnes ‘pseudo-do-
mains’ in a given crystal structure, followed by a hierarchical
reﬁnement of large to local-scale movements, ﬁtting to the SAXS
curve [80].
If a given crystal structure is lacking electron density for parts of
the structure (e.g. loops or termini), these can be modeled based on
SAS data [77], and also more extensive missing regions can be
modeled in a hybrid high-resolution/bead-model/explicit model
approach [81]. A particularly useful application of this approach is
in the modeling of membrane protein structures, embedded into
nanodisks [82]. There, the availability of the complementary in-
formation from neutrons and X-rays is prerequisite for the model
development. This is one example of how orthogonal data can
reduce ambiguity, and hence increase the level of complexity that
Fig. 3. Intrinsic disorder is captured in BioSAXS analysis. Ensembles of structures,
representative for the distribution of the very large number of conformations present
in solution, can be derived from SAXS data, here represented in a pioneering study of
tau protein [105]. Entry ID PED7AAD.
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And back to basics: for any modeling, the correct assessment of
basic data characteristics, such as perfect background subtraction,
evaluation of the mono- or polydispersity of a given sample [42],
assessment of the meaningful data-range [45], and optimal evalu-
ation of discrepancies between models and data [15] remain
crucial. However sophisticated a given modeling approach may be
one can only derive the information that actually resides in the
data. And irrespective of the quality of a given model, one must
never forget the inherent ambiguity in SAS modeling, leaving the
responsibility of independent model evaluation by complementary
experiments and/or evaluation based on prior knowledge on the
researcher.
6. Polydisperse samples
As mentioned above, in most tools for SAXS-based 3D modeling
it is assumed that data are from monodisperse samples. However,
polydispersity is an inherent structural parameter of many mac-
romolecules, such as e.g. intrinsically disordered proteins (see
below), multi-domain proteins, partially formed complexes and
developing systems (Fig. 4).
An important extension of the rigid body modeling tools is
found in SASREFMX [83] which allows modeling against data fromFig. 4. Dynamic protein structural equilibriums. Structural characterization of heterogene
analysis of macromolecular systems that cannot easily be characterized by other structural b
disordered N-terminus (lighter green, a number of potential conformations are shown). SAX
for evaluation of existing high-resolution structures [131] and for modeling of intrinsic diso
monomer-dimer equilibrium and protein structural changes can with advantage be chara
conditions (ﬁbrils are sketched in orange colors (not to scale with the monomeric protein))
process [132], since there are very few restrictions on SAXS sample preparations.polydisperse samples, e.g. transient or weak complexes, where the
protomers exist in a mixture of bound and free states. To lower the
ambiguity level, data recorded at different conditions (e.g. varying
protein concentration) should be included. If the complexity of the
sample extends further, e.g. when analyzing a partial complex
formation which induces structural changes of individual proto-
mers [58], or when analyzing evolving mixtures such as e.g. protein
ﬁbrillation reactions [84e89], it is necessary to apply different
tools. A SAXS spectrum is the product of the structure factor and
form factor contributions. While the form factor describes the
scattering contribution from the individual scatterer (e.g. the pro-
tein) the structure factor describes the interaction between parti-
cles (i.e. repulsive or attractive effects, causing an ordering of the
particles (proteins) in solution). If the structure factors are negli-
gible, SAXS data are additive. This means that in these ideal cases,
data from a mixture of different proteins will equal the sum of the
scattering curves from the individual scattering components,
weighted by their relative volume fractions. In principle, it is hence
possible to decompose such mixture data into the pure spectra
from individual species, and indeed there are tools to do this. The
program OLIGOMER can calculate the volume fractions (relative
weights) of individual components in a mixture, if the (theoretical
or experimental) SAXS proﬁles for each component are available
[90]. When in possession of data where the relative concentrations
of the individual species are varied, e.g. by varying the protein
concentration, temperature or other experimental conditions, or by
measuring along a given reaction coordinate over time or via
titration, it is also principally possible to derive the pure spectra of
individual species, which are not known prior to the experiment
(e.g. Refs. [84e89]). As above, either prior knowledge about a
number of components must be available, and/or their corre-
sponding volume fractions. Prior knowledge about the pure spectra
can be either experimental or theoretical (from e.g. homology
models or docking models), and prior knowledge about volume
fractions can be based on spectroscopy or other orthogonal data
sources. Indeed the decomposition is burdened by ambiguity thus
it is important to use orthogonal data to conﬁrm the validity of the
procedure. Such complex data can also with advantage be analyzed
using chemometrics based approaches for the actual decomposi-
tion procedure (see e.g. Refs. [59,91]). Once decomposed, the pure
spectra can evidently be analyzed and used for modeling, as
described above and hence the actual decomposition is the
bottleneck for analyzing data from complex mixtures.ous macromolecular states is challenging. SAXS is a versatile method, applicable to the
iology methods [128]. The hypothetical monomeric protein (green) has an intrinsically
S is very useful for low-resolution characterization of the solution structure [129,130],
rder [109]. The N-terminus becomes ordered upon dimer formation (red:purple). The
cterized by SAXS analysis [128]. The protein ﬁbrillates under particular experimental
. These experimental conditions can be applied during SAXS analysis of the ﬁbrillation
B. Vestergaard / Archives of Biochemistry and Biophysics 602 (2016) 69e79 757. Protein ﬁbrillation, analyzed by SAXS and SANS
The formation of ﬁbrils from amyloid proteins associates with at
least 20, often fatal, diseases, including the neurodegenerative
Alzheimers and Parkinsons diseases [92,93]. A ﬁbrillating amyloid
protein is a rather extreme example of a polydisperse, developing
system, which is inherently difﬁcult to analyze structurally (Fig. 4).
The protein evolves from its native state into mm-long extended
structures, via intermediate structural states. Such intermediate
states are suggested to associate with cytotoxicity [94], which only
exist in equilibrium with the native and ﬁbril states, and hence
cannot be puriﬁed from the reaction mixture without the risk of
perturbing the structure. It is thus a prerequisite for analysis that it
is possible to work on undisturbed mixtures in solution, which
applies to SAXS and SANS. In addition, the reaction is highly sen-
sitive to the experimental conditions applied [95,96], which makes
it a signiﬁcant advantage that there are very few restrictions on the
experimental conditions that can be applied in a SAXS analysis.
Given the very broad range of resolution, that is covered in SAXS
data, themethod is particularly suitable for ﬁbrillation analysis, and
SAXS data can bridge between high-resolution and low-resolution
data, such as we demonstrated in a study of the hierarchically
organized ﬁbrils of a heptapeptide fragment of prion protein [97].
In a pioneering SANS study on the development of b-lactoglobulin
ﬁbrillation, the data were ﬁtted to a model with charged spheres
and long cylinders (representing monomers and ﬁbrils respec-
tively), yielding the concentration proﬁles and hence a model of the
ﬁbrillation kinetics [98]. Our ﬁrst SAXS-based ﬁbrillation study of
human insulin provided the ﬁrst-ever solution structure of a
transient oligomeric amyloidogenic structure, determined without
perturbing the reaction mixture [88]. We used data decomposition
to isolate the scattering contribution from the intermediate struc-
ture, which was never present in solution alone, and we applied ab
initio modeling to both the intermediate and ﬁbril structures. The
presence of such an intermediate species was also observed for
glucagon ﬁbrillation [99] and later for a and later for DAT [100]. In
the latter case, the observed dimensions of intermediate and ﬁbrils
structures made us suggest that ﬁbrils would form by oligomer
stacking, a model which was corroborated in a later study [87],
where the intermediate structures were stabilized by a small-
molecule compound [101]. One great challenge in investigating
ﬁbrillation processes is the fact that several pathways of aggrega-
tion may co-exist and, that small experimental changes will induce
also structural/pathway changes thus several oligomeric formsmay
form. Indeed, structurally different aSN oligomeric forms have been
observed by SAXS by others than us [102], and as of now, it remains
elusive which of such intermediates, if any, are relevant for estab-
lishing a molecular understanding of cytotoxic effect [94]. In other
cases, our SAXS analyses have shown that the ﬁbrillation proceeds
without accumulation of signiﬁcant amounts of intermediate
oligomers [85,97]. Rather, in the case of transthyretin ﬁbrillation,
we revealed that a highly unfolded monomer co-exists and
assumingly interchanges with the amyloid protoﬁbrils [85]. If
indeed such a ﬁbrillar state interchanges with the soluble state, this
may be a key for understanding the catalytic effects observed when
seeding with ﬁbril material, and/or in the kinetics proﬁles [103].
8. Intrinsically disordered and highly ﬂexible proteins
Two classes of proteins escaping structural elucidation by MX
are multi-domain proteins with extensive ﬂexible linkers, and
intrinsically disordered proteins (IDPs). In the former case func-
tionality closely links with the extensive ﬂexibility and the 3D space
covered by the ﬂexible systems, and this phenomenon is not
described by single crystal structures (although evidently the high-resolution information about the individual domains is still highly
valuable) [56]. In the latter case, the IDP proteins lack structural
characteristics that are well described by classical structural terms.
The range of intrinsic disorder can vary from termini or loops to
larger fractions or entire proteins. This, however, does not imply
that these structures are random. Rather, these proteins should be
described as an ensemble of a very large, ill-deﬁned number of
conformations, each occurring with certain probability. This prob-
ability distribution is evidently as deﬁned by amino acid sequence
as any type of structure, however no individual conformation de-
scribes the structure:function relationship of this type of protein,
but the weighted sum of conformations does.
SAXS is well suited for the investigation of this type of mole-
cules. The Kratky plot (q2I(q) versus q), can be used to visualize the
(lack of) compactness of a protein (see e.g. Ref. [104]). A folded
protein will display an approximated 1/q4 decreasing scattering
intensity at higher q-range, while a random chain will display 1/q2
behavior. This means that these two extremes are very easily
distinguished in a Kratky plot. For in-between cases, such as a
partially folded protein or an intrinsically disordered protein, the
Kratky plot will display distinct features that can easily, qualita-
tively be recognized and one can readily visualize the transition of
e.g. a structured protein to a chemically denatured protein, or
distinguish native intrinsic disorder from chemically denatured
proteins [104].
It is, however, also possible to obtain much more structural in-
formation from this class of proteins based on SAXS data. One can
simplify the problem of describing such ensembles of structures as
an extension of the challenge of describing complex mixtures, only
in this case with an astronomically large number of individual
conformations being represented in the sample. Evidently this
simpliﬁcation is not entirely just, but it serves to illustrate the basic
idea behind ensemble modeling (Fig. 3).
In SAXS-based ensemble modeling, originally pioneered by
Bernado et al. [106] the sum of calculated scattering curves from an
ensemble of conformations, picked from a very large pool of
possible conformations, is ﬁtted to the experimental curve [106].
Due to the ambiguity problem several combinations will describe
the data equally well. For this reason the process must be ran-
domized and repeated, e.g. by applying a genetic algorithm as
originally advocated by Bernado et al. in the program EOM [106], an
approach also implemented in ASTEROIDS, which has the signiﬁ-
cant advantage that coupled reﬁnement against NMR and SAXS
data can be performed [107,108]. Also the size of the conforma-
tional ensemble must be reﬁned during the procedure [109], and
the statistics of the individual selections must guide the ﬁnal se-
lection. An elegant recent development in ensemble selection is the
sparse ensemble selection method, which sets the upper limit of
the ensemble size based on the experimental information content
[110]. A representation of the overall biophysical parameters (e.g.
Rg, Dmax or inter-domain distances in multi-domain proteins) of the
selected pool versus the random pool is a way of presenting the
results [106,109]. Such a representation plots the distribution of
conformational features that represents the experimental data,
rather than just the average bulk value and hence is superior and
provides more information than any average calculation. It is
however not possible to determine the total number of confor-
mations present in the sample, and the selected ensemble is
representative of the overall features specifying the structure of
this particular IDP under these particular experimental conditions.
Alternative approaches focus on selecting minimal ensembles,
basis set ensembles or a smaller number of clusters of conforma-
tions (similar at lower resolution) that adequately ﬁt the data
[111e113]. The principal focus here is to avoid over-ﬁtting of the
data, which may happen by including too many free parameters
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thinking is in that way orthogonal to the original idea, where it is
advocated that since IDPs are weighted ensembles of a very large
number of conformations, then also the ﬁtting should include a
statistical representation of a potentially large number of such
conformations [106]. In the more minimalistic approaches,
although the sum of scattering curves from the minimal set of
conformations does ﬁt to the experimental data, this does not mean
that these particular conformations are the actual and only con-
formations present in solution. Again, the conformations are
regarded as representative for the degree of ﬂexibility of the
molecule under investigation. Not only the selection procedure, but
also the generation of the initial pool varies in the different
ensemble approaches available. The initial conformational pool can
be random, assuring a full coverage of the 3D space [106] and may
contain just the monomeric representation of the protein or also
include e.g. symmetric oligomers [109], or the pool can be enriched
by certain conformations, generated by the user and hence based
on prior knowledge [114]. Arguably one of the most advanced
method available so far for generating the initial pool (and which
was originally developed for the use in NMR reﬁnement [115]) is
ﬂexible meccano, including prior knowledge about the structural
propensity for the speciﬁc amino acids [116]. In this latter case, the
starting pool is in accordance with the genetically encoded infor-
mation in the peptide chain, and hence enriched by basic knowl-
edge, thus should be a superior starting point compared to a
random or subjectively enriched pool. The recently published BE-
SAXS method stands out from the rest, in that it applies a
Bayesian probabilistic model for the SAXS data and generation of
protein structures when ﬁtting to the experimental scattering
proﬁles [117]. The method has the advantage that an arbitrary
number of structures can be included in the ensemble without
increasing the number of parameters ﬁtted to the data, and,
particularly, the implicit advantages of probabilistic modeling of
the protein structure [70,117].
No matter the implied strategy, the important point is that it is
possible to use BioSAXS to select an ensemble of structures,
representative for the typically occurring structural features of the
sample, and hence to obtain a kind of relative structural repre-
sentation. Importantly, a database of ensemble descriptions of
intrinsically disordered proteins or highly ﬂexible proteins, called
pE-DB, has been established [118], collecting results from the very
challenging analysis of such systems. All structures are sensitive to
the experimental conditions, but the adaptive structural nature is
more pronounced for intrinsically disordered proteins, hence it is
an extra strength that the SAXS data can be recorded under
numerous experimental conditions, thereby to a higher extent
exploring the conformational space of a given intrinsically disor-
dered protein.
9. SAXS is central in hybrid methods
SAXS is, as evidenced, a highly valid stand-alone method for the
analysis of even highly complex macromolecular samples. Yet
BioSAXS gains even further importance when considering hybrid
methods, coupling BioSAXS with orthogonal structural and bio-
physical methods [119,120]. Not only is this a way of circumventing
the ambiguity problem associated with SAXS-only modeling, but
also SAXS offers information which is often complementary to
other types of data. One of the particular SAXS features is the
extensive q-range covered by the method hence SAXS contributes
with information on a broad length-scale, covering from sub-nm to
mm scale. A very common and useful combination of methods is MX
and BioSAXS, which was already discussed above.
Evidently, numerous other methods have been coupled withSAXS analysis. One example combines atomic force microscopy and
SAXS. It was shown that the protein gephyrin, part of the post-
synaptic protein complex in inhibitory synapses and consisting of
two domains separated by an extended unfolded domain, exists
primarily as a trimer and in a mixed compact/extended state [121].
An increasingly popular combination of methods with
numerous successful applications is the combination of nuclear
magnetic resonance (NMR) and SAXS [122,123]. The time- and
length-scales of the dynamics that are captured by the two
methods beautifully complement each other, as exempliﬁed in the
study of the dynamic equilibrium between monomers and dimers
of full-length capsid protein fromHIV-1 [124]. This study includes a
temporal description of the extensive dynamics of the N-terminal
domain respective to the C-terminal oligomerization domain. NMR
and SAXS data were also coupled in the de novo structure deter-
mination of the dimer of the BetV1 protein Aha1, and the interface
from this solution-based structure differed from those observed in
crystallo [125]. In a study of the folding pathways of b-2-
microglobulin it was demonstrated that a long-lived intermediate
state has a high aggregation propensity and incorporates into both
homo- and heterodimers, suggesting that excited state dimers
would potentially initiate amyloid aggregation [126].
In a different study the multi-domain N-terminal part of human
cardiac myosin binding protein is characterized [127]. This protein
includes regions exhibiting intrinsic disorder, and indeed the study
of IDP is particularly suitable by the powerful combination of NMR
and SAXS and several programs elegantly couple reﬁnement from
NMR and SAXS data [108,114,115,123]. A recent study of the
intrinsically disordered amyloid proteins aSN and tau is a prime
example of the coupling of atomic resolution information and long-
range information from SAXS data [108].
10. Spatio-temporally resolved models
The development at leading synchrotron beamlines is breath-
taking, and the opportunities, focused around BioSAXS, are rapidly
expanding. Of particular interest are the time-resolved small and
wide angle X-ray scattering (SAXS/WAXS) opportunities [133,134]
emerging with the fast detectors, reﬁned data collection protocols
and advanced sample environments (e.g. pump-probe, stopped-
ﬂow, microﬂuidics) as already reviewed above [24e29]. The ﬁeld
has recently been nicely reviewed [135] and only two examples are
included here: In a recent example cooperative allostery in the
tetrameric interface of wildtype and mutant haemoglobin is
observed at nanosecond time resolution upon photo-induction
[136]; in a different study stopped ﬂow experiments causing a
sudden pH-jump were used to resolve millisecond aggregation of
mutant apomyoglobin leading via a transiently formed monomeric
species to ﬁbrils [137]. Both examples reveal the potential of the
methodology, where highly complex processes including compli-
cated mixtures can be followed at increasingly high spatial and
temporal resolution.
A completely different type of resolution may be achieved if
coupling the currently possible high-resolution single-particle
cryo-electron microscopy (cryo-EM) analysis [138] with advanced
BioSAXS analysis. The revolution in cryo-EM enables not only high-
resolution de novo structure determination but also the description
of mixed states, present in the sample. Here, the complementarity
of solution scattering may play a future important role in aiding to
validate the relevant number of structural states that should be
reﬁned from the cryo-EM data, just as the presence of the high-
resolution structures, present on the cryo-EM grid, could be vali-
dated in solution. Time will show what will be possible, but it does
seem fair to say that the recent and current revolutionary devel-
opment in the BioSAXS ﬁeld likely will continue, probably even at
B. Vestergaard / Archives of Biochemistry and Biophysics 602 (2016) 69e79 77an increased speed. As always, the large-scale facilities play a
central role. The amazing technological developments at synchro-
tron beamlines pull the development in the ﬁeld, enabling ever
more daunting experiments in the fascinating world of structural
biology.
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